Recruiting Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma NCT06860594 Conditions Astrocytoma, Astrocytoma, IDH-Mutant, Grade 2, Glioblastoma, +22 more Locations City of Hope Comprehensive Cancer Center — Duarte, California, United States UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California, United States UC San Diego Moores Cancer Center — La Jolla, California, United States UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California, United States View all 43 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma NCT06815029 Conditions Astrocytoma, Glioblastoma, Glioma, +18 more Locations City of Hope Medical Center — Duarte, California, United States View Trial Details
